Botox Exempt From Medicare Price Talks, Judge Rules
The Centers for Medicare & Medicaid Services can't subject AbbVie's Botox to Medicare price negotiations under the Inflation Reduction Act, a D.C. federal judge held, finding CMS misinterpreted an IRA exclusion...To view the full article, register now.
Already a subscriber? Click here to view full article